Similar articles for PMID: 20392606

Year	Number of Results
2000	1
2001	7
2002	7
2003	20
2004	7
2005	8
2006	8
2007	9
2008	10
2009	11
2010	14
2011	14
2012	13
2013	13
2014	17
2015	9
2016	3
2017	3
2018	8
2019	11
2020	6
2021	13
2022	11
2023	4
2024	0

1

Higher linezolid exposure and higher frequency of thrombocytopenia in patients with renal dysfunction.

Matsumoto K, Takeshita A, Ikawa K, Shigemi A, Yaji K, Shimodozono Y, Morikawa N, Takeda Y, Yamada K. Matsumoto K, et al. Int J Antimicrob Agents. 2010 Aug;36(2):179-81. doi: 10.1016/j.ijantimicag.2010.02.019. Epub 2010 Apr 13. Int J Antimicrob Agents. 2010. PMID: 20392606

2

High plasma linezolid concentration and impaired renal function affect development of linezolid-induced thrombocytopenia.

Nukui Y, Hatakeyama S, Okamoto K, Yamamoto T, Hisaka A, Suzuki H, Yata N, Yotsuyanagi H, Moriya K. Nukui Y, et al. J Antimicrob Chemother. 2013 Sep;68(9):2128-33. doi: 10.1093/jac/dkt133. Epub 2013 Apr 26. J Antimicrob Chemother. 2013. PMID: 23625638

3

Analysis of thrombocytopenic effects and population pharmacokinetics of linezolid: a dosage strategy according to the trough concentration target and renal function in adult patients.

Matsumoto K, Shigemi A, Takeshita A, Watanabe E, Yokoyama Y, Ikawa K, Morikawa N, Takeda Y. Matsumoto K, et al. Int J Antimicrob Agents. 2014 Sep;44(3):242-7. doi: 10.1016/j.ijantimicag.2014.05.010. Epub 2014 Jun 24. Int J Antimicrob Agents. 2014. PMID: 25108880

4

Retrospective cohort chart review study of factors associated with the development of thrombocytopenia in adult Japanese patients who received intravenous linezolid therapy.

Niwa T, Suzuki A, Sakakibara S, Kasahara S, Yasuda M, Fukao A, Matsuura K, Goto C, Murakami N, Itoh Y. Niwa T, et al. Clin Ther. 2009 Oct;31(10):2126-33. doi: 10.1016/j.clinthera.2009.10.017. Clin Ther. 2009. PMID: 19922883

5

Pharmacokinetics and tolerance of single- and multiple-dose oral or intravenous linezolid, an oxazolidinone antibiotic, in healthy volunteers.

Stalker DJ, Jungbluth GL, Hopkins NK, Batts DH. Stalker DJ, et al. J Antimicrob Chemother. 2003 May;51(5):1239-46. doi: 10.1093/jac/dkg180. Epub 2003 Mar 28. J Antimicrob Chemother. 2003. PMID: 12668582 Clinical Trial.

6

High frequency of linezolid-associated thrombocytopenia among patients with renal insufficiency.

Lin YH, Wu VC, Tsai IJ, Ho YL, Hwang JJ, Tsau YK, Wu CY, Wu KD, Hsueh PR. Lin YH, et al. Int J Antimicrob Agents. 2006 Oct;28(4):345-51. doi: 10.1016/j.ijantimicag.2006.04.017. Epub 2006 Aug 28. Int J Antimicrob Agents. 2006. PMID: 16935472

7

Thrombocytopenia and anemia caused by a persistent high linezolid concentration in patients with renal dysfunction.

Tsuji Y, Hiraki Y, Matsumoto K, Mizoguchi A, Kobayashi T, Sadoh S, Morita K, Kamimura H, Karube Y. Tsuji Y, et al. J Infect Chemother. 2011 Feb;17(1):70-5. doi: 10.1007/s10156-010-0080-6. Epub 2010 Jun 26. J Infect Chemother. 2011. PMID: 20582446

8

Linezolid-associated thrombocytopenia.

Lam S. Lam S. Consult Pharm. 2012 Jul;27(7):504-8. doi: 10.4140/TCP.n.2012.504. Consult Pharm. 2012. PMID: 22910131

9

Safety and tolerability of linezolid.

French G. French G. J Antimicrob Chemother. 2003 May;51 Suppl 2:ii45-53. doi: 10.1093/jac/dkg253. J Antimicrob Chemother. 2003. PMID: 12730142 Review.

10

Renal function as a predictor of linezolid-induced thrombocytopenia.

Matsumoto K, Takeda Y, Takeshita A, Fukunaga N, Shigemi A, Yaji K, Shimodozono Y, Yamada K, Ikawa K, Morikawa N. Matsumoto K, et al. Int J Antimicrob Agents. 2009 Jan;33(1):98-9. doi: 10.1016/j.ijantimicag.2008.07.002. Epub 2008 Sep 14. Int J Antimicrob Agents. 2009. PMID: 18790615 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

191 results

Results by year